![](https://investorshub.advfn.com/uicon/515354.png?cb=1605015277)
Sunday, August 18, 2019 12:00:38 AM
shell3 -
Now June July and more than half August already spent and do they have the cash to go 13 more days and Quote above say until January 2nd, 2020
Good Luck as I believe they already out of Cash and 13 more days just digs deeper and no way make January 2020
You took a quote from the Short Form Prospectus which states the company has funds through November 2019.
To date, that’s more than 3 months of cash.
Yet, with absolutely no proof, it’s your “belief “management is flat-out lying in their filed documents.
Who do you think Renmark Financial Communications is talking to on behalf of Algernon...ihub message board potheads?
You appear to dismiss the Annual Information Form and Short Form Prospectus.
If those numbers are not on the money you’re alluding to potential fraud.
Not to mention, Algernon has the exact same Chief Financial Officer (CFO) as Cannabix.
God forbid someone claimed bogus numbers were being reported at Cannabix.
The Camp Cannabix - North & South would go bats**t crazy in defense of the same CFO.
Moving forward >`>`>`
shell3 -
I just don’t see Kal giving up the Keys to the store and a Reverse just gives him a tighter Hold
Where is Kal?
Perhaps he’s busy being the President/Director of Cannabix?
Maybe he’s busy running another company he just took over (Growmax)?
It honestly sounds like a soap opera where Kal remains the villain of the story.
Why is there never a mention of the actual CEO of Algernon?
We can’t stick him into the plot?
I guess we’ll all have to rely on the corporate video.
Moving forward >`>`>`
shell3 -
That alone shows to even to gain the low end $2.5M Offering is .13 BTHCF and the Share Price Friday Close was .0925 and 41% above Friday’s close
Getting the $5M would be great for Holders as that’s 0.357 AGN or .27 BTHCF and the Share Price Friday Close was .0925 and 192% above Friday’s close
One problem is you fail to apply the foreign exchange rate @ BTHCF.
Therefore, you will never get to real world numbers in your calculations.
Either way, your numbers are changing from one week to the next.
Where’d the 500M Reauthorization number come from?
How about Algernon simply take a page out of Cannabix's files?
Cannabix Technologies Inc -
Authorized: Unlimited number of common shares without par value
BUT HOLD UP
Let’s get to the underlying pot here... I mean plot here:
Algernon is conducting a Public Offering and Reverse Split at the same damn time!
Basically, it’s a plot that requires a documented crime be committed in broad daylight.
Like watching POTUS sign some bogus executive order that clearly violates the Constitution.
Only without personal responsibility/repercussions.
There is no diplomatic immunity @ Algernon pharmaceuticals.
The plot only thickens by adding more BS.
Moving forward >`>`>`
shell3 -
Medical Breathalyzer will come and you can bet it’ll do better than any Drug Repositiong (JMO)
What I know is the market for Algernon’s Repurposed Drugs is currently 33.5 times larger than breath analyzers market.
It’s 35 times larger once IPF is loaded into the clinical trial pipeline.
investorshub.advfn.com/boards/read_msg.aspx?message_id=150457312
Breath Analyzer - 1.6 Billion Dollar Market - Timeline ????
NASH|CKD|IBD - 53.6 Billion Dollar Market - Timeline Q3 2020 & Q1 2021
So instead of talking up the Repurposed Drugs strategy at Algernon, knock it down to keep speculating about a device that Algernon clearly put in the backseat.
Face the facts, Algernon and Cannabix’s future are no longer in the same boat.
shell3 -
And THC vs the 17 Disease that use 13 Molecules to detect in Breath is already known threw NaNose work then throw in Owlstone knowledge their chasing from Breath
THC @ BLO
THC @ AGN
All Things Pot-o-lyzers
Here’s a question: Under what medical scenario would someone need a breath analysis to detect THC?
So now THC is a disease?
Better yet, the pothead is going to show up at the emergency room with a THC overdose?
Check any other pothead message board and the answers are resoundingly NO.
Nevermind...let’s just keep making s**t up as we move along.
Meanwhile, Algernon has reported that once a device is completed (no timeline), the device will be handed to a Third-party to advance the device towards Research Use Only (RUO).
It's independent researchers who will chase after whatever whatever...not Algernon Pharmaceuticals.
A viable market for a POC RUO device may be the key to near term monetization.
However, the commercial use of a breathalyzer to detect diseases will require FDA clinical trials.
Anyone here other than shell3 looking forward to a decade of Pot-o-lyzer clinical trials?
In addition, the Nanose device has been thoroughly debunked.
There isn’t a long here that doesn’t know the Nanose device cost us time and money.
It went out the door right along with the resignation of Guy Tatorre 2 Years Ago.
Why continue resurrecting a failed device/technology from the dead?
Oh, I get it.
It’s never about what’s written in black and white.
I’m going to contact management and ask them if they can start delivering news release etched, carved, set in stone, and hand delivered by a guy named Moses.
shell3 -
And as Posted before - I’m not a current Holder and I am here for the Breathalyzer and wished the Cash Reserve was left for the Breathalyzer instead of the Pockets of Insiders to gain from Investors here
GL2ALL
/////AMG >`>`>`
Outro:
Another Repurposed Drugs Scenario
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM